Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.

Mona AflakiAlexandria FlanneryJoão Pedro FerreiraMatthew Pellan ChengNadine KronfliAriane MarelliFaiez ZannadJames BrophyJon AfillaloThao HuynhNadia GiannettiAmal BessissowJustin A EzekowitzRenato D LopesAndrew P AmbrosyMorgan CraigAbhinav Sharma

Published in: Trials (2021)

Trial registration: ClincalTrials.gov : NCT04508985 , date of registration: August 11th , 2020 FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.

Keyphrases

coronavirus disease
randomized controlled trial
angiotensin ii
sars cov
angiotensin converting enzyme
study protocol
healthcare
clinical trial
respiratory syndrome coronavirus
emergency department
phase iii
open label